Question 10

Electronic prescription records for controlled substances must be maintained for 2 years.

Electronic prescription records for controlled substances are required to be maintained for a period of two years, as specified by the DEA regulations. This ensures proper tracking and accountability in the handling of controlled substances.

A) 1

Option A is incorrect because the DEA mandates a longer retention period. Maintaining records for only one year would not comply with federal regulations and would hinder the ability to track prescription patterns effectively.

B) 2

Option B is correct since the DEA specifically requires that electronic prescription records for controlled substances be retained for two years. This policy supports regulatory compliance and enhances the monitoring of controlled substance prescriptions.

C) 3

Option C is incorrect as it exceeds the required retention period. While maintaining records for three years might seem prudent, it does not align with the DEA's specified duration and could lead to unnecessary complications in record-keeping.

D) 4

Option D is also incorrect because it significantly surpasses the two-year requirement set by the DEA. Retaining records for four years would not only be non-compliant but also create storage and management challenges that are not justified by the regulatory framework.

Conclusion

The requirement to maintain electronic prescription records for two years is a crucial regulation enforced by the DEA to ensure accountability and oversight in the prescription of controlled substances. Options A, C, and D fail to meet the specified timeframe, making B the only correct and compliant choice.